Beconase

Cellulitis, Asthma, Nasal Polyps + 10 more
Treatment
20 Active Studies for Beconase

What is Beconase

Beclomethasone dipropionateThe Generic name of this drug
Treatment SummaryBeclomethasone dipropionate is a steroid medication used to reduce inflammation and treat symptoms associated with asthma, allergies, and skin conditions. It is available in a pressurized metered-dose inhaler, dry powder inhaler, and aqueous nasal spray. Beclomethasone dipropionate is less irritating to the nasal mucosa and works longer than older corticosteroids, such as dexamethasone and prednisolone, when administered intranasally.
Beconase AQis the brand name
Beconase Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Beconase AQ
Beclomethasone dipropionate
1989
29

Effectiveness

How Beconase Affects PatientsBeclomethasone dipropionate is a drug used to treat conditions caused by inflammation, such as asthma, allergic rhinitis, and skin conditions. When taken as an inhalant, it can improve lung function, help with breathing, and reduce asthma symptoms. However, long-term use or large doses may affect the body's hormone system, reduce bone density, and interfere with growth, particularly in children. It also has the potential to weaken the immune system and increase the risk of developing infections.
How Beconase works in the bodyBeclomethasone dipropionate is a corticosteroid that helps fight inflammation. It works by binding to the glucocorticoid receptors in cells and signals them to produce anti-inflammatory proteins. It also stops the production of pro-inflammatory proteins that cause chronic inflammation. Lastly, it helps to relax the DNA around the cells, preventing transcription factors from activating genes that cause inflammation.

When to interrupt dosage

The prescribed dosage of Beconase is contingent upon the diagnosed condition, such as Adrenal Cortex Hormones, Dermatosis and Nasal Polyps. The amount of dosage is contingent upon the delivery system (e.g. Aerosol, metered; Suspension - Nasal or Powder - Respiratory (inhalation)) indicated in the table beneath.
Condition
Dosage
Administration
Cellulitis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Asthma
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Nasal Polyps
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Nasal Polyps
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Operation on nose
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Dermatosis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Skin Diseases
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
corticosteroid responsive
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Hay Fever
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Sinusitis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Rhinitis, Allergic
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Sinusitis
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal
Rhinitis, Vasomotor
, 0.042 mg, 0.04 mg, 0.08 mg, 0.1 mg, 0.2 mg, 0.025 %, 0.25 mg/mL, 0.087 mg, 0.172 mg, 0.088 mg, 0.25 mg/pump actuation, 0.1 mg/pump actuation, 0.05 mg/pump actuation, 0.04 mg/pump actuation, 0.08 mg/pump actuation
, Spray, suspension, Nasal, Spray, suspension - Nasal, Respiratory (inhalation), Aerosol, metered - Respiratory (inhalation), Aerosol, metered, Aerosol, metered; Suspension, Aerosol, metered; Suspension - Nasal, Suspension - Nasal, Powder, Powder - Respiratory (inhalation), Topical, Cream - Topical, Cream, Aerosol, metered - Nasal, Spray, Nasal; Respiratory (inhalation), Aerosol, metered - Nasal; Respiratory (inhalation), Suspension, Lotion - Topical, Lotion, Capsule - Respiratory (inhalation), Capsule, Spray - Nasal

Warnings

Beconase has six contraindications and should not be employed concurrently with the conditions in the below table.Beconase Contraindications
Condition
Risk Level
Notes
Cellulitis
Do Not Combine
Tuberculosis
Do Not Combine
Status Asthmaticus
Do Not Combine
infected skin lesions
Do Not Combine
Virus Diseases
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Beclomethasone Dipropionate may interact with Pulse Frequency
There are 20 known major drug interactions with Beconase.
Common Beconase Drug Interactions
Drug Name
Risk Level
Description
2-Methoxyethanol
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with 2-Methoxyethanol.
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Abatacept
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Abatacept.
Abemaciclib
Major
The metabolism of Abemaciclib can be increased when combined with Beclomethasone dipropionate.
Abetimus
Major
The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Abetimus.
Beconase Toxicity & Overdose RiskThe toxic dose of beclometasone dipropionate in rats is greater than 3750mg/kg. Inhalation of high amounts of this drug over a short period can reduce the activity of the hypothalamus, pituitary gland, and adrenal glands. If beclometasone dipropionate is used excessively over a long period, it may cause adrenal suppression.

Beconase Novel Uses: Which Conditions Have a Clinical Trial Featuring Beconase?

A total of 252 active clinical trials are being conducted to assess the potential of Beconase in treating corticosteroid-responsive dermatoses, Chronic Obstructive Pulmonary Disease (COPD) and Perennial Allergic Rhinitis (PAR).
Condition
Clinical Trials
Trial Phases
Asthma
92 Actively Recruiting
Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3
Skin Diseases
0 Actively Recruiting
Nasal Polyps
4 Actively Recruiting
Phase 2, Phase 3, Phase 4
corticosteroid responsive
0 Actively Recruiting
Hay Fever
0 Actively Recruiting
Sinusitis
0 Actively Recruiting
Cellulitis
0 Actively Recruiting
Rhinitis, Allergic
0 Actively Recruiting
Operation on nose
0 Actively Recruiting
Dermatosis
0 Actively Recruiting
Rhinitis, Vasomotor
0 Actively Recruiting
Sinusitis
6 Actively Recruiting
Early Phase 1, Phase 2, Phase 3, Phase 1
Nasal Polyps
0 Actively Recruiting

Beconase Reviews: What are patients saying about Beconase?

5Patient Review
6/29/2009
Beconase for Inflammation of the Nose due to an Allergy
Though it's an older drug, this steroid is still effective for twelve hours. I imagine the patent running out has something to do with the lack of advertisement. Helps a ton with seasonal allergies and can also act as a light psycho-stimulant if taken orally (in pill form).

Patient Q&A Section about beconase

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Beconase the same as Nasonex?

"The side effects of Nasonex that are different from those of Beconase include coughing, muscle or joint pain, blood-tinged mucus/phlegm, and nosebleeds. The side effects of Beconase that are different from those of Nasonex include sneezing, runny nose, lightheadedness, unpleasant taste or smell, or itching or rash."

Answered by AI

What type of drug is Beconase?

"Beconase is a medication that belongs to a class of drugs called corticosteroids. These drugs are designed to be taken intranasally, which means they are meant to be inhaled through the nose."

Answered by AI

What is Beconase used to treat?

"The spray works by reducing the inflammation in your nose.

Beclometasone is a nasal spray used to treat the symptoms of allergic rhinitis, which is an inflammation of the inside of the nose. The spray works by reducing the inflammation in the nose."

Answered by AI

Has Beconase got a steroid in it?

"The active ingredient in Beconase is a corticosteroid. Corticosteroids quickly reduce inflammation and swelling in the nasal passage, which reduces the symptoms of hayfever, such as an itching or blocked nose."

Answered by AI

Clinical Trials for Beconase

Have you considered Beconase clinical trials? We made a collection of clinical trials featuring Beconase, we think they might fit your search criteria.Go to Trials
Image of Allergy Immunology Associates in Mayfield Heights, United States.

Osteopathic Manipulative Treatment for Asthma

18 - 60
All Sexes
Mayfield Heights, OH
Asthma is a common respiratory condition that can be difficult to control despite the use of medications such as inhalers, oral steroids or even injectable medications. Osteopathic Manipulative Treatment (OMT) is a hands-on technique used to improve the chest structure and function and may help in improving breathing. Previous research showed that OMT in asthma patients, can improve the movement of the ribs and improve the "peak flow" which is the maximum rate at which a person can exhale air after taking a deep breath. However, no studies have evaluated the impact of OMT on lung inflammation. This single-site research study at University Hospitals aims to evaluate whether Osteopathic Manipulative Treatment (OMT) can reduce lung inflammation and improve breathing and lung function in adult patients with asthma. The lung function will be evaluated by Spirometry which is a test that measures how much air you can breathe in and out of your lungs, as well as how quickly and easily you can exhale air. The lung inflammation will be measured using a device that can detect how much you are breathing out Nitric Oxide which is a gas produced by inflamed cells in the lungs, this test is called: Fractional exhaled Nitric Oxide or FeNO. Approximately 100 participants will be enrolled.
Waitlist Available
Has No Placebo
Allergy Immunology AssociatesNancy Wasserbauer-Kingston, DO
Image of DARTNet Institute in Aurora, United States.

Inhaled Corticosteroids + Azithromycin for Asthma

13 - 75
All Sexes
Aurora, CO
While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects. This study will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Maintenance And Reliever Therapy) or PARTICS (Patient Activated Reliever Trigger Inhaled Corticosteriods) therapy - either of these therapies will be called Rescue-Inhaled Corticosteroids or R-ICS pronounced "Ricks," and (2) use of azithromycin (AZ) as a preventive therapy. These treatments will be studied both individually and in combination.
Phase 4
Recruiting
DARTNet Institute (+12 Sites)Wilson D Pace, MD, FAAFP
Image of Medical Place Pharmacy in Ajax, Canada.

Pharmacy Support System for Asthma

Any Age
All Sexes
Ajax, Canada
The goal of this study is to assess the effect of an electronic asthma management system in pharmacies (eAMS-Pharm) on asthma control assessment, asthma medication adjustment, asthma action plan delivery, and prompting for specialist referral in severe asthma. The study assesses the differences on pharmacy processes (affecting both the pharmacy team and patients) and pharmacy-delivered care using an interrupted time-series analysis (six-months before vs. six-months after the introduction of eAMS-Pharm in study pharmacy sites). The eAMS-Pharm uses patient data (asthma control, asthma flare-up risk, and current medications) to provide clinical decision support to pharmacists, empowering them to bridge existing gaps between guideline-recommended asthma care and patient care received.
Waitlist Available
Has No Placebo
Medical Place Pharmacy (+2 Sites)
Image of St. Paul's Hospital in Vancouver, Canada.

Salbutamol for Athletic Performance

18 - 55
All Sexes
Vancouver, Canada
β2-Agonists, commonly used to treat asthma, have also been used by athletes to enhance performance, leading to their ban by the International Olympic Committee in 1972. Research has shown non-asthmatics receive no benefit from these drugs at therapeutic dosages; however, many elite athletes still use them, and asthmatic athletes often win more Olympic medals. In some non-asthmatics, β2-agonists may improve breathing limitations during high intensity exercise, which may improve performance. Therefore, we aim to examine if there is a select group of non-asthmatic individuals who experience breathing limitations that may receive benefit from β2-agonists.
Waitlist Available
Paid Trial
St. Paul's HospitalJordan A Guenette, PhD
Have you considered Beconase clinical trials? We made a collection of clinical trials featuring Beconase, we think they might fit your search criteria.Go to Trials
Image of Velocity Clinical Research, Mobile in Mobile, United States.

PF-07275315 for Asthma

18 - 70
All Sexes
Mobile, AL
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 18 to 70 years old * Have had moderate-to-severe asthma for at least 12 months that is not well controlled * Have been taking their regular maintenance treatment(s) for asthma over the last 12 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 12 weeks. We will compare the experiences of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants will be involved in this study for about 9.5 months. During this time, they will have 10 visits at the study clinic.
Phase 2
Recruiting
Velocity Clinical Research, Mobile (+10 Sites)Pfizer CT.gov Call CenterPfizer
Image of St. Joseph's Healthcare Hamilton in Hamilton, Canada.

Corticosteroids for Asthma

18+
All Sexes
Hamilton, Canada
Most individuals with asthma can effectively manage their symptoms and maintain normal lung function using inhaled medications, unfortunately, there is a subset of asthma sufferers whose symptoms, lung function, and risk of asthma attacks remain unimproved despite conventional inhaled medications. There could be several reasons for this. One possibility is that inhaled medications fail to reach the intended areas within the lungs, due to structural abnormalities within the airways themselves. Much like road conditions or closures can impede the speed and efficiency of vehicle travel, factors such as airway narrowing or mucus blockages, which are common in asthma, can obstruct the passage of inhaled medications through the airways. Our team has now optimized advanced medical imaging techniques, including magnetic resonance imaging (MRI) and computed tomography (CT), required to investigate this. This study will use these imaging methods to visually assess and measure individual patients' airways and determine whether abnormal airway structures impact how well they respond to inhaled and orally delivered medications. We anticipate finding that abnormal airway structures make inhaled medications less effective, but that they do not affect the response to oral medications.
Phase 4
Recruiting
St. Joseph's Healthcare Hamilton (+1 Sites)
Have you considered Beconase clinical trials? We made a collection of clinical trials featuring Beconase, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security